| Literature DB >> 29265814 |
Zhanchao Meng1, Laetitia Souillart1, Brendan Monks1, Nikolas Huwyler1, Jennifer Herrmann2, Rolf Müller2, Alois Fürstner1.
Abstract
The highly cytotoxic cyclodepsipeptides of the nannocystin family are known to bind to the eukaryotic translation elongation factor 1α (EF-1α). Analysis of the docking pose, as proposed by a previous in silico study, suggested that the trisubstituted alkene moiety and the neighboring methyl ether form a domain that might be closely correlated with biological activity. This hypothesis sponsored a synthetic campaign which was designed to be "motif-oriented": specifically, a sequence of ring closing alkyne metathesis (RCAM) followed by hydroxy-directed trans-hydrostannation of the resulting cycloalkyne was conceived, which allowed this potentially anchoring substructure to be systematically addressed at a late stage. This inherently flexible approach opened access to nannocystin Ax (1) itself as well as to 10 non-natural analogues. While the biological data confirmed the remarkable potency of this class of compounds and showed that the domain in question is indeed an innate part of the pharmacophore, the specific structure/activity relationships can only partly be reconciled with the original in silico docking study; therefore, we conclude that this model needs to be carefully revisited.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29265814 DOI: 10.1021/acs.joc.7b02871
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354